WebJun 30, 2024 · Series B convertible preferred stock, par value $ 0.01 per share: 1,500,000 shares authorized, no shares issued and outstanding Common stock, par value $ 0.01 per share; 325,000,000 shares authorized; 174,813,326 shares issued and outstanding at June 30, 2024 and 127,183,109 shares issued and outstanding at September 30, 2024 WebFind the latest press releases from Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2024 (OTLKW) at Nasdaq.com.
Stock Warrants 101: What Are They and How Do They Work?
WebJun 25, 2024 · Zacks Equity Research. Outlook Therapeutics, Inc. OTLK was a big mover last session, as the company saw its shares rise 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company —as the stock is now up 84.5% in the past one-month time frame. WebMay 18, 2024 · OTLKW - Outlook Therapeutics Inc. Series A ... Log In; Search for... OTLKW – Outlook Therapeutics Inc. Series A Warrant Expiring 02/18/2024. by Stocks News Feed; … cough and heart palpitations
OTLKW – Outlook Therapeutics Inc. Series A Warrant Expiring …
WebFeb 18, 2024 · Outlook Therapeutics Inc - Warrants - Series A (18/02/2024) Stock Forecast, OTLKW stock price prediction. Price target in 14 days: 0.0953 USD. The best long-term & … WebOTLKW Outlook Therapeutics Inc Current Report Filing (8-k) Support: 888-992-3836 WebApr 10, 2024 · Each share of common stock is being sold together with one 15-month warrant to purchase one share of common stock and one 5-year warrant to purchase one … cough and heart issue